Figure 1
Frequent detection of anti-gp41 mucosal immunoglobulin (Ig)A, but infrequent detection of mucosal anti-gp120 IgA within 133 days from enrollment. Frequency of HIV-specific antibodies in (a, b) plasma in 14–30 CHAVI 001 subjects and (c, d) mucosal sites in 13–23 CHAVI 001 subjects within 133 days of enrollment. IgG and IgA specific for the immunodominant epitope of gp41 were also tested in mucosal samples from 12 individuals. nt, not tested.
